tirzepatide synergy nash Will the GLP-1 giants kill the smid-caps? Tough week for some smid-cap NASH stocks 2/6/24 $LLY announced π’ β’ positive Ph2 MASH (AKA NASH) data β¨ MASH resolution (74%) of SYNERGY-NASH: Tirzepatide, a GIP/GLP-1 RA,
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14


















:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)








